1. Home
  2. RCUS vs GLP Comparison

RCUS vs GLP Comparison

Compare RCUS & GLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • GLP
  • Stock Information
  • Founded
  • RCUS 2015
  • GLP 2005
  • Country
  • RCUS United States
  • GLP United States
  • Employees
  • RCUS N/A
  • GLP N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • GLP Oil Refining/Marketing
  • Sector
  • RCUS Health Care
  • GLP Energy
  • Exchange
  • RCUS Nasdaq
  • GLP Nasdaq
  • Market Cap
  • RCUS 1.4B
  • GLP 1.7B
  • IPO Year
  • RCUS 2018
  • GLP 2005
  • Fundamental
  • Price
  • RCUS $14.45
  • GLP $51.17
  • Analyst Decision
  • RCUS Buy
  • GLP Strong Buy
  • Analyst Count
  • RCUS 12
  • GLP 1
  • Target Price
  • RCUS $34.50
  • GLP $54.00
  • AVG Volume (30 Days)
  • RCUS 835.5K
  • GLP 73.1K
  • Earning Date
  • RCUS 11-06-2024
  • GLP 11-08-2024
  • Dividend Yield
  • RCUS N/A
  • GLP 5.73%
  • EPS Growth
  • RCUS N/A
  • GLP N/A
  • EPS
  • RCUS N/A
  • GLP 3.31
  • Revenue
  • RCUS $263,000,000.00
  • GLP $17,386,440,000.00
  • Revenue This Year
  • RCUS $112.97
  • GLP $26.21
  • Revenue Next Year
  • RCUS N/A
  • GLP $22.37
  • P/E Ratio
  • RCUS N/A
  • GLP $15.35
  • Revenue Growth
  • RCUS 119.17
  • GLP 5.31
  • 52 Week Low
  • RCUS $13.50
  • GLP $33.38
  • 52 Week High
  • RCUS $20.31
  • GLP $52.00
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 37.76
  • GLP 61.75
  • Support Level
  • RCUS $14.19
  • GLP $48.20
  • Resistance Level
  • RCUS $15.01
  • GLP $52.00
  • Average True Range (ATR)
  • RCUS 0.98
  • GLP 1.23
  • MACD
  • RCUS -0.22
  • GLP 0.28
  • Stochastic Oscillator
  • RCUS 7.41
  • GLP 74.33

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About GLP Global Partners LP Common Units representing Limited Partner Interests

Global Partners LP is an U.S.-based limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

Share on Social Networks: